Fitbit’s upcoming Sense smartwatch is the most advanced health tracker to date. And that claim grew stronger when the company got FDA approval to turn on its EKG electrocardiogram heart monitor (EKG) app before the watch is even released.
A smartwatch EKG monitors your heart rhythm and looks for signs of atrial fibrillation (AFib), the most common type of irregular heartbeat. Due to the impact of health surveillance, companies need FDA approval before they can offer the feature to users.
“Helping people understand and manage their heart health has always been a priority for Fitbit. Our new EKG app is designed for users who want to assess themselves right now and check the reading with their doctor later,”
AFib can be difficult to spot and increases the risk of stroke. Often times, people don’t realize they were in AFib until they have had a stroke. Eventually, early detection can lead to better health outcomes.
After the Apple Watch and Samsung, the Fitbit Sense is the third smartwatch with an app approved for ECG. The approval comes just in time so that Fitbit can publish the new device with the function activated, which Samsung did not manage with the Galaxy Active2.